Meloxicam and Micro-k drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Meloxicam (meloxicam) and Micro-k (potassium chloride). Common drug interactions include abdominal pain among females and metastases to central nervous system among males.

The phase IV clinical study analyzes what interactions people have when they take Meloxicam and Micro-k. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Meloxicam?

Meloxicam has active ingredients of meloxicam. It is often used in arthritis. eHealthMe is studying from 68,016 Meloxicam users. Check the latest studies of Meloxicam.

What is Micro-k?

Micro-k has active ingredients of potassium chloride. It is often used in hypokalemia. eHealthMe is studying from 1,895 Micro-k users. Check the latest studies of Micro-k.



On Jul, 11, 2026

11 people who take Meloxicam and Micro-k together, and have interactions are studied.

Meloxicam and Micro-k drug interactions.

What are the common drug interactions of Meloxicam and Micro-K, by gender? *:

female:

  1. Abdominal pain
  2. Diarrhoea
  3. Dizziness
  4. Haematoma (collection of blood outside the blood vessels)
  5. Hypotension (abnormally low blood pressure)
  6. Intermittent claudication
  7. Multiple injuries
  8. Musculoskeletal chest pain (pain in chest muscle or nerve or bones)
  9. Abdominal distension
  10. Angina pectoris (chest pain due to ischemia of the heart muscle)

male:

  1. Metastases to central nervous system (cancer spreads to central nervous system)
  2. Metastases to liver (cancer spreads to liver)
  3. Metastases to lymph nodes (cancer spreads to lymph node)
  4. Metastases to pancreas (cancer spreads to pancreas)
  5. Metastases to spleen (cancer spreads to spleen)
  6. Metastatic malignant melanoma (spreadable cancer tumour of melanine)

What are the common drug interactions of Meloxicam and Micro-K, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Insomnia (sleeplessness)
  2. Intervertebral disc degeneration (spinal disc degeneration)
  3. Intervertebral disc operation
  4. Intervertebral disc protrusion (spinal disc protrusion)
  5. Joint range of motion decreased (disease of joint movement)
  6. Limb injury
  7. Lumbar vertebral fracture
  8. Lymph node pain
  9. Memory impairment
  10. Mental impairment (a condition affecting the body, perhaps through sight or hearing loss, a mobility difficulty or a health condition)

50-59:

  1. Chronic kidney disease
  2. Febrile neutropenia (fever with reduced white blood cells)
  3. Pneumonia
  4. Renal failure (kidney dysfunction)
  5. Renal injury (kidney injury)
  6. Convulsive threshold lowered
  7. Diarrhoea

60+:

  1. Abdominal pain
  2. Cardiac failure congestive
  3. Angina pectoris (chest pain due to ischemia of the heart muscle)
  4. Anxiety
  5. Bradycardia (abnormally slow heart action)
  6. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  7. Dizziness
  8. Hypertension (high blood pressure)
  9. Hypotension (abnormally low blood pressure)
  10. Loss of consciousness

What are the existing conditions these people have? *

  1. Pain: 4 people, 36.36%
  2. Type 2 Diabetes: 2 people, 18.18%
  3. Simple Partial Seizures (seizures which affect only a small region of the brain): 2 people, 18.18%
  4. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 2 people, 18.18%
  5. Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 2 people, 18.18%
  6. Complex Partial Seizures (epileptic seizure): 2 people, 18.18%
  7. Diabetes: 2 people, 18.18%
  8. Migraine (headache): 2 people, 18.18%
  9. Insomnia (sleeplessness): 2 people, 18.18%
  10. Faeces Hard: 2 people, 18.18%

* Approximation only. Some reports may have incomplete information.

Do you take Meloxicam and Micro-k?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Meloxicam and Micro-k:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Meloxicam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Micro-k:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Meloxicam and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Micro-k and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on meloxicam and potassium chloride (the active ingredients of Meloxicam and Micro-k, respectively), and Meloxicam and Micro-k (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: